Establishment Labs to Announce First Quarter 2024 Financial Results on May 8
Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, plans to announce its
BusinesswireApr 24 08:30 ET
Establishment Labs Announces Participation in The Aesthetic Meeting 2024
Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced its
BusinesswireApr 17 08:30 ET
Establishment Labs Is Maintained at Buy by Citigroup
Establishment Labs Is Maintained at Buy by Citigroup
Dow JonesApr 3 11:56 ET
Citigroup Maintains Buy on Establishment Labs Hldgs, Raises Price Target to $60
Citigroup analyst Joanne Wuensch maintains Establishment Labs Hldgs (NASDAQ:ESTA) with a Buy and raises the price target from $49 to $60.
BenzingaApr 3 11:46 ET
Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and Gritstone Oncology (GRTS)
TipRanksApr 3 05:32 ET
Establishment Labs Says US FDA Schedules Preapproval Inspection of Motiva Implants Facility
Establishment Labs (ESTA) said Tuesday that the US Food and Drug Administration scheduled a PMA preapproval inspection of the company's manufacturing facility for Motiva Implants. The inspection is se
MT NewswiresApr 2 11:47 ET
Establishment Labs Is Maintained at Buy by Mizuho
Establishment Labs Is Maintained at Buy by Mizuho
Dow JonesApr 1 07:59 ET
Express News | Mizuho Maintains Buy on Establishment Labs Hldgs, Raises Price Target to $65
Moomoo 24/7Apr 1 07:48 ET
10 Health Care Stocks Whale Activity In Today's Session
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth.
BenzingaMar 29 13:35 ET
Establishment Labs Poised for Robust Growth With Motiva Expansion and Upcoming Market Entries
TipRanksMar 20 00:15 ET
Establishment Labs Is Maintained at Outperform by TD Cowen
Establishment Labs Is Maintained at Outperform by TD Cowen
Dow JonesMar 12 11:44 ET
Express News | TD Cowen Maintains Outperform on Establishment Labs Hldgs, Raises Price Target to $60
Moomoo 24/7Mar 12 11:33 ET
Buy Rating Affirmed for Establishment Labs on Positive FDA Approval Progress and Strong GMP Preparedness
TipRanksMar 12 04:15 ET
New Regulation Risk for Establishment Labs Holdings – What's the Latest?
TipRanksMar 5 01:00 ET
Establishment Labs Holdings Up Over 23%, on Pace for Largest Percent Increase Since October 2020 -- Data Talk
Establishment Labs Holdings, Inc. ( ESTA ) is currently at $47.34, up $8.89 or 23.1% --Would be highest close since Sept. 29, 2023, when it closed at $49.07 --On pace for largest percent increase si
Dow JonesFeb 29 12:53 ET
Establishment Labs Price Target Raised to $53.00/Share From $46.00 by JP Morgan
Establishment Labs Price Target Raised to $53.00/Share From $46.00 by JP Morgan
Dow JonesFeb 29 11:35 ET
Establishment Labs Is Maintained at Overweight by JP Morgan
Establishment Labs Is Maintained at Overweight by JP Morgan
Dow JonesFeb 29 11:35 ET
Hormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Nasdaq Composite gaining around 50 points on Thursday. Shares of Hormel Foods Corporation (NYSE:HRL) rose sharply during Thursday's session after the company reporte
BenzingaFeb 29 11:30 ET
Express News | JP Morgan Maintains Overweight on Establishment Labs Hldgs, Raises Price Target to $53
Moomoo 24/7Feb 29 11:24 ET
Establishment Labs Hldgs Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 02/29/2024 16.48% JP Morgan $46 → $53 Maintains Overweight 01/11/2024 3.29% Stephens & Co. → $47 Reiterate
BenzingaFeb 29 11:23 ET
No Data
No Data